| Full Name | Lawrence H. Moore |
|---|---|
| Speciality | Clinical Neuropsychologist |
| Location | 2009 F Street, Vancouver, Washington |
| Authorized Official Name and Position | Lawrence Harold Moore (VICE-PRESIDENT) |
| Authorized Official Contact | 3606933715 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence H. Moore 2009 F Street Vancouver WA 98663 Ph: (360) 693-3715 | Lawrence H. Moore 2009 F Street Vancouver WA 98663 Ph: (360) 693-3715 |
| NPI Number | 1033325501 |
|---|---|
| Provider Enumeration Date | 05/14/2007 |
| Last Update Date | 01/21/2015 |
| Medicare PECOS PAC ID | 2365332384 |
|---|---|
| Medicare Enrollment ID | O20040316000127 |
News Archive
Alcohol and attitudes are two of the key factors that health professionals need to be aware of when they are dealing with sexually active teenagers.
Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.
Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.
In an attempt to create a single device that can image and treat tumors simultaneously, researchers at the University of Texas Southwestern Medical Center at Dallas have successfully melded magnetic iron nanoparticles, the anticancer drug doxorubicin, and a polymer tagged with a tumor-targeted molecule into a stable nanoparticle that accumulates inside human tumor cells.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033325501 | NPI | - | NPPES |
| 7078918 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103G00000X | Clinical Neuropsychologist | 2014 (Washington) | Primary |
| Provider Name | Lawrence H Moore |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1215143821 PECOS PAC ID: 7517857535 Enrollment ID: I20040330000797 |
News Archive
Alcohol and attitudes are two of the key factors that health professionals need to be aware of when they are dealing with sexually active teenagers.
Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.
Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.
In an attempt to create a single device that can image and treat tumors simultaneously, researchers at the University of Texas Southwestern Medical Center at Dallas have successfully melded magnetic iron nanoparticles, the anticancer drug doxorubicin, and a polymer tagged with a tumor-targeted molecule into a stable nanoparticle that accumulates inside human tumor cells.
› Verified 1 days ago
| Provider Name | Taryn E Markee |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1548312630 PECOS PAC ID: 2062302086 Enrollment ID: I20040330001036 |
News Archive
Alcohol and attitudes are two of the key factors that health professionals need to be aware of when they are dealing with sexually active teenagers.
Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.
Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.
In an attempt to create a single device that can image and treat tumors simultaneously, researchers at the University of Texas Southwestern Medical Center at Dallas have successfully melded magnetic iron nanoparticles, the anticancer drug doxorubicin, and a polymer tagged with a tumor-targeted molecule into a stable nanoparticle that accumulates inside human tumor cells.
› Verified 1 days ago
| Provider Name | Ryan Mangum |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1790311157 PECOS PAC ID: 8123441805 Enrollment ID: I20200714001626 |
News Archive
Alcohol and attitudes are two of the key factors that health professionals need to be aware of when they are dealing with sexually active teenagers.
Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.
Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.
In an attempt to create a single device that can image and treat tumors simultaneously, researchers at the University of Texas Southwestern Medical Center at Dallas have successfully melded magnetic iron nanoparticles, the anticancer drug doxorubicin, and a polymer tagged with a tumor-targeted molecule into a stable nanoparticle that accumulates inside human tumor cells.
› Verified 1 days ago
News Archive
Alcohol and attitudes are two of the key factors that health professionals need to be aware of when they are dealing with sexually active teenagers.
Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.
Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.
In an attempt to create a single device that can image and treat tumors simultaneously, researchers at the University of Texas Southwestern Medical Center at Dallas have successfully melded magnetic iron nanoparticles, the anticancer drug doxorubicin, and a polymer tagged with a tumor-targeted molecule into a stable nanoparticle that accumulates inside human tumor cells.
› Verified 1 days ago
Fletcher Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr, Suite 292, Vancouver, WA 98684 Phone: 360-524-5879 Fax: 360-326-1834 | |
Daybreak Vancouver Outpatient Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11818 Se Mill Plain Blvd, Suite 307, Vancouver, WA 98684 Phone: 360-750-9635 Fax: 360-334-9541 | |
Sleep Health Clinic Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2501 Ne 134th St Ste 203, Vancouver, WA 98686 Phone: -- | |
Awaken Counseling, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4602 Ne 59th Ave, Vancouver, WA 98661 Phone: 503-410-3048 | |
Vancover Treatment Solutions Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2009 Ne 117th Street, Ste. 101, Vancouver, WA 98686 Phone: 360-566-9112 Fax: 360-566-9133 | |
Moontree Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3305 Main St Ste 23, Vancouver, WA 98663 Phone: 360-949-2727 | |
Dale B Mortimer Md Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10000 Ne 7th Ave, Suite 385, Vancouver, WA 98685 Phone: 360-882-9058 Fax: 360-567-0861 |